login

Telomere length, risk of coronary heart disease, and statin treatment in the West of Scotland Primary Prevention Study: a nested case-control study

The LancetPublished 1 January 2007
Scott Brouilette, J. Moore, Alex D. McMahon, John R. Thompson, Ian Ford, James Shepherd
Citations748
SJR quartileQ1
SJR score12.11
SNIP22.72

TL;DR

Mean leucocyte telomere length is a predictor of future coronary heart disease events in middle-aged, high-risk men and could identify individuals who would benefit most from statin treatment.

Abstract

Mean leucocyte telomere length is a predictor of future coronary heart disease events in middle-aged, high-risk men and could identify individuals who would benefit most from statin treatment. Our findings lend support to the hypothesis that differences in biological ageing might contribute to the risk--and variability in age of onset--of coronary heart disease.

Keywords

Medicine